vimarsana.com

Page 44 - காப்புரிமை பெற்றது மருந்துகள் ஒழுங்குமுறைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IP Australia – Exceptional Support For Users Disrupted By COVID-19 - Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com. The COVID-19 pandemic is causing global disruption, and entire sectors of the economy are being shut down to limit infection. During this difficult time, IP Australia, which includes the Australian Patent Office, the Designs Office and the Trade Marks Office, is supporting individuals and businesses who use the patent, designs, plant breeder s rights and trade mark systems. The Australian Government has announced extensive support to individuals and businesses impacted by COVID-19, including tax assistance for people impacted by COVID-19, special measures which exempt specified treatments for COVID-19 from

Virpax Pharmaceuticals Announces Newly Issued Patent for Probudur

CUSMA: Canadian Patent Applications To Be Eligible For Patent Term Adjustment For Unreasonable Prosecution Delays - Intellectual Property

The 411 On File Wrapper Estoppel In Canada - Intellectual Property

To print this article, all you need is to be registered or login on Mondaq.com. In Canada, it has long been understood that when it comes to the construction of claims in a patent litigation matter, only information provided by the four corners of the specification was admissible in the court proceeding. This means that the claims were purposively construed with a mind willing to understand and based on the teachings of the description. More than 20 years ago, the highest court in Canada affirmed that allowing extrinsic evidence, in the form of admissions made during the prosecution of the Canadian patent

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.